Global contributions of pharmacists during the COVID-19 pandemic
© 2020 Pharmacotherapy Publications, Inc..
Throughout the SARS-CoV-2 (COVID-19) global pandemic, pharmacists were rarely mentioned as essential frontline health care providers by the news media, the public, or politicians. Around the world, pharmacists are working on the frontlines of health care every day providing essential health care services during the pandemic. Pharmacists are medication experts providing patient care in a variety of settings including hospitals, clinics, community pharmacies, long-term care, physician offices, and national and public health. In this paper, we describe how pharmacists from high and low-middle income countries contributed to essential patient care and well-being of the public during the COVID-19 pandemic. While the news media, the public, and politicians often overlooked pharmacists as essential frontline health care providers, we hope that this list of contributions by pharmacists from nine countries in this article can help to change this perspective.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
Journal of the American College of Clinical Pharmacy : JACCP - 3(2020), 8 vom: 30. Dez., Seite 1480-1492 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goff, Debra A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibiotic stewardship |
|---|
| Anmerkungen: |
Date Revised 16.07.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/jac5.1329 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316131067 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316131067 | ||
| 003 | DE-627 | ||
| 005 | 20231225160421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jac5.1329 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1053.xml |
| 035 | |a (DE-627)NLM316131067 | ||
| 035 | |a (NLM)33043280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goff, Debra A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Global contributions of pharmacists during the COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2020 Pharmacotherapy Publications, Inc. | ||
| 520 | |a Throughout the SARS-CoV-2 (COVID-19) global pandemic, pharmacists were rarely mentioned as essential frontline health care providers by the news media, the public, or politicians. Around the world, pharmacists are working on the frontlines of health care every day providing essential health care services during the pandemic. Pharmacists are medication experts providing patient care in a variety of settings including hospitals, clinics, community pharmacies, long-term care, physician offices, and national and public health. In this paper, we describe how pharmacists from high and low-middle income countries contributed to essential patient care and well-being of the public during the COVID-19 pandemic. While the news media, the public, and politicians often overlooked pharmacists as essential frontline health care providers, we hope that this list of contributions by pharmacists from nine countries in this article can help to change this perspective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a antibiotic stewardship | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a global health | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a pharmacists | |
| 650 | 4 | |a pharmacy | |
| 700 | 1 | |a Ashiru-Oredope, Diane |e verfasserin |4 aut | |
| 700 | 1 | |a Cairns, Kelly A |e verfasserin |4 aut | |
| 700 | 1 | |a Eljaaly, Khalid |e verfasserin |4 aut | |
| 700 | 1 | |a Gauthier, Timothy P |e verfasserin |4 aut | |
| 700 | 1 | |a Langford, Bradley J |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoud, Sara Fouad |e verfasserin |4 aut | |
| 700 | 1 | |a Messina, Angeliki P |e verfasserin |4 aut | |
| 700 | 1 | |a Michael, Ubaka Chukwuemeka |e verfasserin |4 aut | |
| 700 | 1 | |a Saad, Thérèse |e verfasserin |4 aut | |
| 700 | 1 | |a Schellack, Natalie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American College of Clinical Pharmacy : JACCP |d 2018 |g 3(2020), 8 vom: 30. Dez., Seite 1480-1492 |w (DE-627)NLM289551536 |x 2574-9870 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2020 |g number:8 |g day:30 |g month:12 |g pages:1480-1492 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jac5.1329 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2020 |e 8 |b 30 |c 12 |h 1480-1492 | ||